Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Alexis

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Dermatology and Therapy|November 13, 2016
Skin Bleaching and Dermatologic Health of African and Afro-Caribbean Populations in the US: New Directions for Methodologically Rigorous, Multidisciplinary, and Culturally Sensitive ResearchEmma K T Benn, Andrew Alexis, Nihal Mohamed, et al.
The Journal of Dermatological Treatment|June 24, 2024
Health disparities in psoriasis: geographic barriers to access in the United StatesLauren Seigel, Sofia Shoaib, Keshia Maughn, et al.
Journal of Drugs in Dermatology : JDD|September 8, 2022
Supplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment RegimensHilary Baldwin, Andrew Alexis, Anneke Andriessen, et al.
The Journal of Clinical and Aesthetic Dermatology|September 12, 2024
Is Acne the Same Around the World?Andrew Alexis, Jerry Tan, Marco Rocha, et al.
Clinical, Cosmetic and Investigational Dermatology|June 24, 2021
The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment ApproachBrigitte Dreno, Jean Michel Amici, Ann Laure Demessant-Flavigny, et al.
Journal of the American Academy of Dermatology|August 25, 2024
A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African AmericansPearl E Grimes, Shanaya Dias, Angela Kyei, et al.
Journal of Drugs in Dermatology : JDD|September 5, 2025
Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot StudyAhuva Cices, Nour El-Kashlan, Bridget Kaufman, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2024
An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of ColorNour El-Kashlan, Ahuva Cices, Bridget Kaufman, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Efficacy and Safety of Secukinumab in the Treatment of Psoriasis in Patients with Skin Phototypes IV to VINour El-Kashlan, Ahuva Cices, Bridget Kaufman, et al.
Cutis|February 18, 2022
Telemedicine Alopecia Assessment: Highlighting Patients With Skin of ColorBritney N Wilson, Amy McMichael, Andrew Alexis, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Dermatology and Therapy|November 13, 2016
Skin Bleaching and Dermatologic Health of African and Afro-Caribbean Populations in the US: New Directions for Methodologically Rigorous, Multidisciplinary, and Culturally Sensitive ResearchEmma K T Benn, Andrew Alexis, Nihal Mohamed, et al.
The Journal of Dermatological Treatment|June 24, 2024
Health disparities in psoriasis: geographic barriers to access in the United StatesLauren Seigel, Sofia Shoaib, Keshia Maughn, et al.
Journal of Drugs in Dermatology : JDD|September 8, 2022
Supplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment RegimensHilary Baldwin, Andrew Alexis, Anneke Andriessen, et al.
The Journal of Clinical and Aesthetic Dermatology|September 12, 2024
Is Acne the Same Around the World?Andrew Alexis, Jerry Tan, Marco Rocha, et al.
Clinical, Cosmetic and Investigational Dermatology|June 24, 2021
The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment ApproachBrigitte Dreno, Jean Michel Amici, Ann Laure Demessant-Flavigny, et al.
Journal of the American Academy of Dermatology|August 25, 2024
A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African AmericansPearl E Grimes, Shanaya Dias, Angela Kyei, et al.
Journal of Drugs in Dermatology : JDD|September 5, 2025
Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot StudyAhuva Cices, Nour El-Kashlan, Bridget Kaufman, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2024
An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of ColorNour El-Kashlan, Ahuva Cices, Bridget Kaufman, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Efficacy and Safety of Secukinumab in the Treatment of Psoriasis in Patients with Skin Phototypes IV to VINour El-Kashlan, Ahuva Cices, Bridget Kaufman, et al.
Cutis|February 18, 2022
Telemedicine Alopecia Assessment: Highlighting Patients With Skin of ColorBritney N Wilson, Amy McMichael, Andrew Alexis, et al.
Pageof 8